Matches in SemOpenAlex for { <https://semopenalex.org/work/W2912368025> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- W2912368025 endingPage "36" @default.
- W2912368025 startingPage "SCI" @default.
- W2912368025 abstract "Abstract Recent technological advances in the detection and characterization of cell free circulating tumor DNA (ctDNA) are providing new opportunities for treatment tailoring based on real-time monitoring of clonal evolution. Circulating biomarkers can provide a liquid biopsy alternative to tissue biopsies allowing noninvasive tumor genotyping and the serial analysis of genomic changes from a simple blood test. The emerging clinical benefits of ctDNA analysis in the management of solid tumours has led to an expansion of opportunities in the use of ctDNA for disease monitoring in haematological malignancies. Research in this area has rapidly expanded exploring the role of ctDNA for risk stratification, monitoring tumour burden and identifying the early emergence of treatment resistance. In the management of lymphoma, comprehensive analysis of somatic genomic alterations in plasma DNA has emerged as an important clinical tool. The use of ctDNA analysis to follow tumour specific genomic alterations identified on an individual basis can be used to help identify minimal residual disease post treatment and guide therapeutic decisions. Moreover, ctDNA analysis can been utilized to identify distinct biological subtypes of lymphoma and provide insights into patterns of genomic evolution following treatment. The role of ctDNA as a minimally invasive strategy for disease monitoring has also recently been demonstrated in chronic lymphocytic leukemia (CLL) showing additional potential of this technique in haematological malignancies with a circulating disease component. In CLL, ctDNA analysis can reveal changes in the disease across tissue compartments, including the bone marrow and lymph nodes, providing additional information to that which can be assessed by monitoring the circulating disease alone. Serial ctDNA analysis in CLL can allow clonal dynamics to be monitored over time and can identify the emergence of genomic changes associated with Richter's syndrome. Here, I will focus on the use of ctDNA technology to follow disease burden and track genomic changes in patients receiving novel therapies for lymphoid malignancies, as well as the promises and challenges in developing these tools for clinical application. Disclosures No relevant conflicts of interest to declare." @default.
- W2912368025 created "2019-02-21" @default.
- W2912368025 creator A5010913192 @default.
- W2912368025 date "2018-11-29" @default.
- W2912368025 modified "2023-09-30" @default.
- W2912368025 title "Clinical Implications and Biomarkers of Clonal Evolution" @default.
- W2912368025 doi "https://doi.org/10.1182/blood-2018-99-109501" @default.
- W2912368025 hasPublicationYear "2018" @default.
- W2912368025 type Work @default.
- W2912368025 sameAs 2912368025 @default.
- W2912368025 citedByCount "0" @default.
- W2912368025 crossrefType "journal-article" @default.
- W2912368025 hasAuthorship W2912368025A5010913192 @default.
- W2912368025 hasBestOaLocation W29123680251 @default.
- W2912368025 hasConcept C104317684 @default.
- W2912368025 hasConcept C113968399 @default.
- W2912368025 hasConcept C121608353 @default.
- W2912368025 hasConcept C126322002 @default.
- W2912368025 hasConcept C135763542 @default.
- W2912368025 hasConcept C142724271 @default.
- W2912368025 hasConcept C143998085 @default.
- W2912368025 hasConcept C203014093 @default.
- W2912368025 hasConcept C2779134260 @default.
- W2912368025 hasConcept C2779338263 @default.
- W2912368025 hasConcept C2779529041 @default.
- W2912368025 hasConcept C2779823535 @default.
- W2912368025 hasConcept C2780007613 @default.
- W2912368025 hasConcept C31467283 @default.
- W2912368025 hasConcept C54355233 @default.
- W2912368025 hasConcept C60644358 @default.
- W2912368025 hasConcept C71924100 @default.
- W2912368025 hasConcept C86803240 @default.
- W2912368025 hasConceptScore W2912368025C104317684 @default.
- W2912368025 hasConceptScore W2912368025C113968399 @default.
- W2912368025 hasConceptScore W2912368025C121608353 @default.
- W2912368025 hasConceptScore W2912368025C126322002 @default.
- W2912368025 hasConceptScore W2912368025C135763542 @default.
- W2912368025 hasConceptScore W2912368025C142724271 @default.
- W2912368025 hasConceptScore W2912368025C143998085 @default.
- W2912368025 hasConceptScore W2912368025C203014093 @default.
- W2912368025 hasConceptScore W2912368025C2779134260 @default.
- W2912368025 hasConceptScore W2912368025C2779338263 @default.
- W2912368025 hasConceptScore W2912368025C2779529041 @default.
- W2912368025 hasConceptScore W2912368025C2779823535 @default.
- W2912368025 hasConceptScore W2912368025C2780007613 @default.
- W2912368025 hasConceptScore W2912368025C31467283 @default.
- W2912368025 hasConceptScore W2912368025C54355233 @default.
- W2912368025 hasConceptScore W2912368025C60644358 @default.
- W2912368025 hasConceptScore W2912368025C71924100 @default.
- W2912368025 hasConceptScore W2912368025C86803240 @default.
- W2912368025 hasIssue "Supplement 1" @default.
- W2912368025 hasLocation W29123680251 @default.
- W2912368025 hasOpenAccess W2912368025 @default.
- W2912368025 hasPrimaryLocation W29123680251 @default.
- W2912368025 hasRelatedWork W2027717767 @default.
- W2912368025 hasRelatedWork W2045348280 @default.
- W2912368025 hasRelatedWork W2171422777 @default.
- W2912368025 hasRelatedWork W2348836856 @default.
- W2912368025 hasRelatedWork W2369117338 @default.
- W2912368025 hasRelatedWork W2371279320 @default.
- W2912368025 hasRelatedWork W2379364167 @default.
- W2912368025 hasRelatedWork W2416406993 @default.
- W2912368025 hasRelatedWork W2418591842 @default.
- W2912368025 hasRelatedWork W74504067 @default.
- W2912368025 hasVolume "132" @default.
- W2912368025 isParatext "false" @default.
- W2912368025 isRetracted "false" @default.
- W2912368025 magId "2912368025" @default.
- W2912368025 workType "article" @default.